181 related articles for article (PubMed ID: 30664827)
1. Structure-Activity and Structure-Toxicity Relationships of Peptoid-Based Histone Deacetylase Inhibitors with Dual-Stage Antiplasmodial Activity.
Mackwitz MKW; Hesping E; Antonova-Koch Y; Diedrich D; Woldearegai TG; Skinner-Adams T; Clarke M; Schöler A; Limbach L; Kurz T; Winzeler EA; Held J; Andrews KT; Hansen FK
ChemMedChem; 2019 May; 14(9):912-926. PubMed ID: 30664827
[TBL] [Abstract][Full Text] [Related]
2. One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.
Diedrich D; Stenzel K; Hesping E; Antonova-Koch Y; Gebru T; Duffy S; Fisher G; Schöler A; Meister S; Kurz T; Avery VM; Winzeler EA; Held J; Andrews KT; Hansen FK
Eur J Med Chem; 2018 Oct; 158():801-813. PubMed ID: 30245402
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the in vitro and in vivo efficacy of peptoid-based HDAC inhibitors with dual-stage antiplasmodial activity.
Mackwitz MKW; Hesping E; Eribez K; Schöler A; Antonova-Koch Y; Held J; Winzeler EA; Andrews KT; Hansen FK
Eur J Med Chem; 2021 Feb; 211():113065. PubMed ID: 33360801
[TBL] [Abstract][Full Text] [Related]
4. Design and Synthesis of Terephthalic Acid-Based Histone Deacetylase Inhibitors with Dual-Stage Anti-Plasmodium Activity.
Stenzel K; Chua MJ; Duffy S; Antonova-Koch Y; Meister S; Hamacher A; Kassack MU; Winzeler E; Avery VM; Kurz T; Andrews KT; Hansen FK
ChemMedChem; 2017 Oct; 12(19):1627-1636. PubMed ID: 28812327
[TBL] [Abstract][Full Text] [Related]
5. Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages.
Hansen FK; Sumanadasa SD; Stenzel K; Duffy S; Meister S; Marek L; Schmetter R; Kuna K; Hamacher A; Mordmüller B; Kassack MU; Winzeler EA; Avery VM; Andrews KT; Kurz T
Eur J Med Chem; 2014 Jul; 82():204-13. PubMed ID: 24904967
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, antimalarial properties, and SAR studies of alkoxyurea-based HDAC inhibitors.
Hansen FK; Skinner-Adams TS; Duffy S; Marek L; Sumanadasa SD; Kuna K; Held J; Avery VM; Andrews KT; Kurz T
ChemMedChem; 2014 Mar; 9(3):665-70. PubMed ID: 24497437
[TBL] [Abstract][Full Text] [Related]
7. Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites.
Engel JA; Jones AJ; Avery VM; Sumanadasa SD; Ng SS; Fairlie DP; Skinner-Adams T; Andrews KT
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):117-26. PubMed ID: 26199860
[TBL] [Abstract][Full Text] [Related]
8. Lysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules.
Trenholme K; Marek L; Duffy S; Pradel G; Fisher G; Hansen FK; Skinner-Adams TS; Butterworth A; Ngwa CJ; Moecking J; Goodman CD; McFadden GI; Sumanadasa SD; Fairlie DP; Avery VM; Kurz T; Andrews KT
Antimicrob Agents Chemother; 2014 Jul; 58(7):3666-78. PubMed ID: 24733477
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors with high in vitro activities against Plasmodium falciparum isolates collected from Gabonese children and adults.
Koehne E; Kreidenweiss A; Zoleko Manego R; McCall M; Mombo-Ngoma G; Mackwitz MKW; Hansen FK; Held J
Sci Rep; 2019 Nov; 9(1):17336. PubMed ID: 31758015
[TBL] [Abstract][Full Text] [Related]
10. Design and Synthesis of Novel Anti-Plasmodial Histone Deacetylase Inhibitors Containing an Alkoxyamide Connecting Unit.
Alves Avelar LA; Held J; Engel JA; Sureechatchaiyan P; Hansen FK; Hamacher A; Kassack MU; Mordmüller B; Andrews KT; Kurz T
Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28317157
[TBL] [Abstract][Full Text] [Related]
11. Fluorescent analogs of peptoid-based HDAC inhibitors: Synthesis, biological activity and cellular uptake kinetics.
Raudszus R; Nowotny R; Gertzen CGW; Schöler A; Krizsan A; Gockel I; Kalwa H; Gohlke H; Thieme R; Hansen FK
Bioorg Med Chem; 2019 Oct; 27(19):115039. PubMed ID: 31420257
[TBL] [Abstract][Full Text] [Related]
12. QSAR Classification Models for Prediction of Hydroxamate Histone Deacetylase Inhibitor Activity against Malaria Parasites.
Hesping E; Chua MJ; Pflieger M; Qian Y; Dong L; Bachu P; Liu L; Kurz T; Fisher GM; Skinner-Adams TS; Reid RC; Fairlie DP; Andrews KT; Gorse AJP
ACS Infect Dis; 2022 Jan; 8(1):106-117. PubMed ID: 34985259
[TBL] [Abstract][Full Text] [Related]
13. Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth.
Chua MJ; Arnold MS; Xu W; Lancelot J; Lamotte S; Späth GF; Prina E; Pierce RJ; Fairlie DP; Skinner-Adams TS; Andrews KT
Int J Parasitol Drugs Drug Resist; 2017 Apr; 7(1):42-50. PubMed ID: 28107750
[TBL] [Abstract][Full Text] [Related]
14. Design, Multicomponent Synthesis, and Anticancer Activity of a Focused Histone Deacetylase (HDAC) Inhibitor Library with Peptoid-Based Cap Groups.
Krieger V; Hamacher A; Gertzen CGW; Senger J; Zwinderman MRH; Marek M; Romier C; Dekker FJ; Kurz T; Jung M; Gohlke H; Kassack MU; Hansen FK
J Med Chem; 2017 Jul; 60(13):5493-5506. PubMed ID: 28574690
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice.
Chua MJ; Tng J; Hesping E; Fisher GM; Goodman CD; Skinner-Adams T; Do D; Lucke AJ; Reid RC; Fairlie DP; Andrews KT
Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():118-127. PubMed ID: 34560571
[TBL] [Abstract][Full Text] [Related]
16. Specific sub fractions from Terminalia mantaly (H. Perrier) extracts potently inhibit Plasmodium falciparum rings, merozoite egress and invasion.
Jiatsa Mbouna CD; Tchatat Tali BM; Tsouh Fokou PV; Madiesse Kemgne EA; Keumoe R; Toghueo Kouipou RM; Yamthe Tchokouaha LR; Tchuente Tchuenmogne MA; Kenou DK; Sahal D; Boyom FF
J Ethnopharmacol; 2022 Mar; 285():114909. PubMed ID: 34902534
[TBL] [Abstract][Full Text] [Related]
17. Novel inhibitor of Plasmodium histone deacetylase that cures P. berghei-infected mice.
Agbor-Enoh S; Seudieu C; Davidson E; Dritschilo A; Jung M
Antimicrob Agents Chemother; 2009 May; 53(5):1727-34. PubMed ID: 19223622
[TBL] [Abstract][Full Text] [Related]
18. Antimalarial activity of the anticancer histone deacetylase inhibitor SB939.
Sumanadasa SD; Goodman CD; Lucke AJ; Skinner-Adams T; Sahama I; Haque A; Do TA; McFadden GI; Fairlie DP; Andrews KT
Antimicrob Agents Chemother; 2012 Jul; 56(7):3849-56. PubMed ID: 22508312
[TBL] [Abstract][Full Text] [Related]
19. Hydroxamic acid based histone deacetylase inhibitors with confirmed activity against the malaria parasite.
Giannini G; Battistuzzi G; Vignola D
Bioorg Med Chem Lett; 2015 Feb; 25(3):459-61. PubMed ID: 25563890
[TBL] [Abstract][Full Text] [Related]
20. Balancing Histone Deacetylase (HDAC) Inhibition and Drug-likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors.
Schäker-Hübner L; Haschemi R; Büch T; Kraft FB; Brumme B; Schöler A; Jenke R; Meiler J; Aigner A; Bendas G; Hansen FK
ChemMedChem; 2022 May; 17(9):e202100755. PubMed ID: 35073610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
